Roelof J C Kluin Selected Research

Roelof J C Kluin Research Topics

Disease

16	Neoplasms (Cancer) 05/2024 - 07/2013
3	Triple Negative Breast Neoplasms 01/2024 - 01/2019
3	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 05/2024 - 10/2021
2	Inflammation (Inflammations) 03/2024 - 01/2019
1	Carcinogenesis 03/2024
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 12/2021
1	Carcinoma (Carcinomatosis) 01/2018
1	Virus Diseases (Viral Diseases) 11/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2013
1	Adenocarcinoma of Lung 07/2013
1	Lung Neoplasms (Lung Cancer) 07/2013
1	Stomach Neoplasms (Stomach Cancer) 03/2013

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 10/2015
3	RNA (Ribonucleic Acid)IBA 10/2021 - 07/2013
3	Phosphotransferases (Kinase)IBA 01/2018 - 07/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2024 - 03/2024
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 11/2013
1	Vorinostat FDA Link 05/2024
1	Histone Deacetylase InhibitorsIBA 05/2024
1	Mitogen-Activated Protein KinasesIBA 03/2024
1	PlasticsIBA 03/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Formaldehyde (Formol)FDA Link 01/2024
1	InterferonsIBA 01/2024
1	ParaffinIBA 01/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024
1	CytokinesIBA 01/2024
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	enzalutamideIBA 01/2022
1	AndrogensIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	EndonucleasesIBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	PlatinumIBA 01/2018
1	tyrosine receptor (receptor, tyrosine)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	AntigensIBA 11/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2013
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 07/2013
1	Cadherins (E-Cadherin)IBA 03/2013
1	CateninsIBA 03/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2013
3	Drug Therapy (Chemotherapy) 01/2024 - 01/2018
1	Transplantation 10/2021